北極星藥業-KY
655013.70−0.60−4.20%收盤・資料日 2026-11-06
營收與獲利單位:億元;資料到 2026 Q2
2026 Q20.07 億元−0.53 億元−5.27 億元−8.47 億元
營收與獲利(億元;單季)
21Q422Q222Q423Q223Q424Q224Q425Q225Q426Q2
損益表單位:億元(每股盈餘:元);單季,最新在左
| 科目 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業收入淨額 | 0.07 | 0.37 | 0.06 | 0.18 | 0.08 | 0.08 | 0.36 | 0.11 | 0.32 | 0.28 | 0.05 | 0.01 | 0.02 | 0.00 | 0.01 | 0.00 | 0.02 | 0.03 | 0.08 | — |
| 營業成本 | 0.60 | 0.83 | 1.20 | 0.71 | 0.71 | 0.48 | 0.70 | 0.45 | 0.36 | 0.33 | 0.08 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.01 | 0.03 | 0.06 | — |
| 營業毛利 | −0.53 | −0.46 | −1.14 | −0.53 | −0.63 | −0.40 | −0.34 | −0.34 | −0.04 | −0.06 | −0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | — |
| 營業費用 | 4.74 | 5.10 | 6.18 | 6.75 | 6.69 | 6.47 | 8.14 | 6.98 | 5.70 | 4.76 | 5.94 | 4.90 | 4.13 | 3.48 | 3.27 | 3.00 | 2.78 | 2.54 | 3.67 | — |
| 推銷費用 | 0.05 | 0.05 | 0.09 | 0.08 | 0.09 | 0.09 | 0.14 | 0.09 | 0.08 | 0.04 | — | — | — | — | — | — | — | — | — | — |
| 管理費用 | 0.53 | 0.77 | 0.65 | 0.80 | 0.77 | 0.88 | 0.87 | 0.72 | 0.86 | 0.85 | 1.07 | 0.74 | 0.61 | 0.65 | 0.56 | 0.57 | 0.47 | 0.74 | 0.89 | — |
| 研究發展費用 | 4.16 | 4.28 | 5.43 | 5.87 | 5.83 | 5.49 | 7.13 | 6.17 | 4.76 | 3.87 | 4.87 | 4.16 | 3.51 | 2.82 | 2.70 | 2.43 | 2.31 | 1.79 | 2.78 | — |
| 預期信用減損損失(利益) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | −0.01 | 0.01 | — | — | — | — | — | — | — | — | — | — |
| 營業利益 | −5.27 | −5.56 | −7.32 | −7.28 | −7.32 | −6.87 | −8.48 | −7.31 | −5.74 | −4.82 | −5.98 | −4.89 | −4.12 | −3.48 | −3.26 | −3.00 | −2.78 | −2.53 | −3.66 | — |
| 營業外收入及支出 | −3.40 | 0.00 | −9.50 | 0.42 | −1.71 | 0.12 | −0.04 | −0.01 | 0.15 | 0.79 | 0.55 | 0.57 | 0.80 | 0.78 | 0.43 | −0.06 | −0.15 | −0.10 | −0.19 | — |
| 財務成本 | 0.08 | 0.15 | 0.30 | 0.29 | 0.25 | 0.16 | 0.13 | 0.16 | 0.15 | 0.13 | 0.15 | 0.07 | 0.08 | 0.02 | 0.02 | 0.02 | 0.02 | 0.05 | 0.09 | — |
| 採權益法認列之關聯企業及合資損益份額 | −0.07 | −0.08 | −0.06 | −0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.13 | 0.00 | −0.03 | −0.03 | −0.03 | −0.02 | −0.02 | −0.02 | −0.05 | — |
| 稅前淨利 | −8.67 | −5.56 | −16.82 | −6.86 | −9.02 | −6.75 | −8.52 | −7.32 | −5.59 | −4.03 | −5.43 | −4.32 | −3.32 | −2.69 | −2.83 | −3.06 | −2.93 | −2.63 | −3.85 | — |
| 所得稅費用 | −0.20 | −0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | −0.01 | 0.03 | 0.00 | 0.08 | 0.01 | 0.02 | 0.04 | 0.05 | 0.00 | 0.00 | 0.00 | 0.01 | — |
| 繼續營業單位損益 | −8.47 | −5.54 | −16.82 | −6.86 | −9.02 | −6.75 | −8.55 | −7.31 | −5.62 | −4.03 | −5.51 | −4.33 | −3.34 | −2.74 | −2.89 | −3.06 | −2.93 | −2.63 | −3.86 | — |
| 本期淨利(稅後) | −8.47 | −5.54 | −16.82 | −6.86 | −9.02 | −6.75 | −8.55 | −7.31 | −5.62 | −4.03 | −5.51 | −4.33 | −3.34 | −2.74 | −2.89 | −3.06 | −2.93 | −2.63 | −3.86 | — |
| 歸屬母公司業主 | −8.47 | −5.54 | −16.82 | −6.86 | −8.94 | −6.66 | −8.44 | −7.18 | −5.50 | −3.91 | −5.44 | −4.25 | −3.33 | −2.74 | −2.89 | −3.06 | −2.93 | −2.63 | −3.86 | — |
| 歸屬非控制權益 | 0.00 | 0.00 | 0.00 | 0.00 | −0.09 | −0.09 | −0.11 | −0.14 | −0.12 | −0.12 | −0.06 | −0.08 | −0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| 本期綜合損益總額 | −8.67 | −4.70 | −15.97 | −5.34 | −14.82 | −6.04 | −6.71 | −8.58 | −4.77 | −1.49 | −8.48 | −1.84 | −1.97 | −3.31 | −5.48 | 1.86 | −0.43 | −0.19 | −4.52 | — |
| 綜合損益歸屬母公司業主 | −8.67 | −4.70 | −15.97 | −5.34 | −14.73 | −5.95 | −6.60 | −8.44 | −4.66 | −1.37 | −8.42 | −1.76 | −1.96 | −3.31 | −5.48 | 1.86 | −0.43 | −0.19 | −4.52 | — |
| 綜合損益歸屬非控制權益 | 0.00 | 0.00 | 0.00 | 0.00 | −0.09 | −0.09 | −0.11 | −0.14 | −0.12 | −0.12 | −0.06 | −0.08 | −0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| 每股盈餘(元) | −0.98 | −0.64 | −2.19 | −0.89 | −1.16 | −0.86 | −1.12 | −0.96 | −0.74 | −0.53 | −0.73 | −0.57 | −0.45 | −0.37 | −0.39 | −0.41 | −0.40 | −0.37 | −0.55 | — |